Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07246902 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mobilization and Outcomes After Venous Closure

Study acronym: MOVE
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 2 entries Show 4 more changesShow less
    • Trial completed
    • Trial sites expanded: 3 → 9 locations
    • Primary and study completion dates changed from estimate of Aug 21, 2026 to Aug 26, 2026
    • Eligibility criteria expanded, about 9 words
  2. Enrollment closed, study ongoing
    • Enrollment increased: 300 → 339 participants
    • Primary and study completion dates: Aug 2026 to Aug 21, 2026
    • Site details revised at 3 of 3 sites
    v4
  3. Study sites: 1 to 3v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 2025 to Nov 24, 2025
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.
Trial Details
NCT Number NCT07246902
Lead Sponsor Cordis US Corp.
Collaborators: NAMSA
Conditions
(from sponsor)		 Venous Vascular Closure, Electrophysiology Study
Enrollment 339 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov